Eli Manning, Theo Epstein, Drive by DraftKings back Spren in closing more than $11 million in seed capital to launch camera-enabled biomarker platform


Spren is a camera-enabled, digital biomarker platform that connects any app to the human body.

“Spren’s breakthrough technology is going to make a positive impact on the health of people across the globe. I’m excited to support this company and its mission,” said Theo Epstein, a three-time World Series-winning baseball executive.

Spren, the company behind top-ranked Heart Rate Variability app Elite HRV, has closed $11.3 million in seed funding to bring its camera-enabled, digital biomarker platform out of stealth mode. This revolutionary technology is designed to empower enterprises across multiple industries and sizes to deliver accurate, evidence-based insights on body composition, heart rate variability (HRV), stress, recovery, cardiovascular fitness, and more.

Led by Drive by DraftKings and featuring notable investors such as two-time Superbowl Champion Eli Manning, MLB Executive and General Manager Theo Epstein, Boston Seed Capital, Karlani Capital, Permit Ventures and others, this Seed funding allows Spren to accelerate expansion of its enterprise biomarker platform into the $1.5 trillion global wellness market.

Spren transforms smartphone cameras into real-time biomarker sensors without additional hardware or wearables. With a few snippets of code, Spren’s SDK and API enhances the user experience through biomarker personalization that improves engagement, retention, and paid conversions. Simultaneously, it helps consumers understand their bodies and make well-informed decisions about their fitness, health, and lifestyle routines.

“So many people need help with their health and well-being, but lack of hardware access can create a serious barrier for many,” Spren Founder & CEO Jason Moore said. “By making targeted biomarker insights more accessible, we’ve already seen hundreds of thousands of people improve their mental and physical well-being. We’re thankful for the support of our investors in fueling our continued innovation and enabling us to accelerate partner integrations that will help us serve millions more people.”

The patented technology behind the Spren platform leverages a decade of research into physiology, behavior and health insights — including collaboration with 117 universities and analysis of more than four billion biomarkers across 20 million user sessions, representing people from all over the world with varying health statuses, performance goals, and lifestyles.

“Measuring stress, recovery and body composition with only a smartphone camera is truly transformative, not just for the sports world but for healthcare overall,” said Theo Epstein, a three-time World Series-winning baseball executive. “Spren’s breakthrough technology is going to make a positive impact on the health of people across the globe. I’m excited to support this company and its mission.”

Expanding on the 715,000+ users of the Elite HRV app, Spren is now rolling out its technology to millions of consumers through partners like Fitbod, Marius Pharmaceuticals, FORTË, and Final Surge.

“We live in a world that cares deeply about living our best lives. Access to tools and technology that enhance our understanding of body composition and the complex signals given off by our bodies play a critical role in ensuring our health, well-being and longevity,” said Meredith McPherron, CEO & Managing Partner of Drive by DraftKings. “The Drive team believes the Spren platform will revolutionize the health and fitness monitoring category and has the real capacity to improve the health of our society generally. We are proud to play such a meaningful role in helping accelerate their journey forward.”

For more information about Spren’s biomarker insights platform, please visit spren.com.

About Spren

Spren is a camera-enabled, digital biomarker platform that connects any app to the human body. Using the smartphone as the sensor, Spren’s evidence-based machine learning algorithms deliver actionable biomarker insights such as HRV, body composition, stress, recovery, progress tracking, and more through an easy to integrate SDK and API. Health and wellness companies are integrating Spren to better understand their users’ holistic health, make their apps more personalized and adaptive, demonstrate measurable progress and empower their members to understand their bodies and make well-informed decisions for their well-being.

Share article on social media or email:

Leave a Reply